Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.69 USD | -1.25% | +17.39% | -11.32% |
May. 14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 102M | Sales 2025 * | 114M | Capitalization | 232M |
---|---|---|---|---|---|
Net income 2024 * | -13M | Net income 2025 * | -12M | EV / Sales 2024 * | 2.28 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.04 x |
P/E ratio 2024 * |
-16.4
x | P/E ratio 2025 * |
-20.2
x | Employees | 136 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.76% |
Latest transcript on OptimizeRx Corporation
1 day | -1.25% | ||
1 week | +17.39% | ||
Current month | +24.41% | ||
1 month | +35.72% | ||
3 months | -19.68% | ||
6 months | +28.57% | ||
Current year | -11.32% |
Managers | Title | Age | Since |
---|---|---|---|
Will Febbo
CEO | Chief Executive Officer | 55 | 16-02-21 |
Edward Stelmakh
DFI | Director of Finance/CFO | 58 | 21-10-10 |
President | 46 | 19-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Wasson
BRD | Director/Board Member | 65 | 20-07-20 |
Catherine Klema
BRD | Director/Board Member | 65 | Jan. 23 |
Patrick Spangler
BRD | Director/Board Member | 68 | 18-03-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 12.69 | -1.25% | 197,610 |
24-05-16 | 12.85 | -2.43% | 250,804 |
24-05-15 | 13.17 | +25.67% | 663,062 |
24-05-14 | 10.48 | -0.57% | 99,408 |
24-05-13 | 10.54 | -2.50% | 91,739 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.32% | 232M | |
+27.57% | 268B | |
+6.66% | 137B | |
+32.61% | 96.13B | |
+6.99% | 92.47B | |
+61.15% | 60.06B | |
+18.75% | 48.02B | |
+24.94% | 37.9B | |
+0.13% | 35.73B | |
+15.50% | 29.23B |
- Stock Market
- Equities
- OPRX Stock